Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference23 articles.
1. Chawla S, Blay J-Y, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, et al. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Lancet Oncol. 2019;20(12):1719–29.
2. WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours: WHO Classification of Tumours (Medicine). 5th ed. International Agency for Research on Cancer; 2020.
3. Santini E, Kalil RK, Franco Bertoni Y-KP. Tumors and tumorlike lesions of bone, vol. 25. Springer; 1994. p. 593–3.
4. Presneau N, Baumhoer D, Behjati S, Pillay N, Tarpey P, Campbell PJ, et al. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. J Pathol Clin Res [Internet]. 2015;1(2):113–23. https://doi.org/10.1002/cjp2.13.
5. Zhang R, Ma T, Qi D, Zhao M, Hu T, Zhang G. Short-term preoperative denosumab with surgery in unresectable or recurrent giant cell tumor of bone. Orthop Surg. 2019;11(6):1101–8.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献